VIRAVAXX GMBH

Follow

Organization

VIENNA, AT

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method for detecting HIV-1-specific antibodies using clade C env po...
- Patent number 11,237,166
- Issue date Feb 1, 2022
- Viravaxx AG
- Rudolf Valenta
- G01 - MEASURING TESTING
Information Patent Grant
Solid support comprising HIV-1 clade C envelope peptides for the de...
- Patent number 10,209,257
- Issue date Feb 19, 2019
- Viravaxx AG
- Rudolf Valenta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for diagnosing a rhinovirus infection
- Patent number 9,638,694
- Issue date May 2, 2017
- Viravaxx GmbH
- Rudolf Valenta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HBV VACCINE INDUCING PRES-SPECIFIC NEUTRALIZING ANTIBODIES
- Publication number 20240382584
- Publication date Nov 21, 2024
- Viravaxx AG
- Inna TULAEVA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fusion Protein
- Publication number 20220048955
- Publication date Feb 17, 2022
- Viravaxx AG
- Rudolf Valenta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for Diagnosing a Viral Infection
- Publication number 20190219576
- Publication date Jul 18, 2019
- Viravaxx AG
- Rudolf Valenta
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fusion Protein
- Publication number 20180244726
- Publication date Aug 30, 2018
- Viravaxx AG
- Rudolf Valenta
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks